RNA reinforces condensate nucleation on chromatin to amplify oncogenic transcription

Krista A. Budinich, Xinyi Yao, Chujie Gong, Lele Song, Xiaoting Wang, Michelle Lee, Sylvia Tang, Qinglan Li, Son C. Nguyen, Eric F. Joyce, Yuanyuan Li, Haitao Li, Liling WanbioRxiv 2025 · DOI

TL;DR

This paper reveals that RNA transcripts, produced locally at specific gene locations, are crucial for the formation and function of oncogenic protein condensates (ENL mutants) that drive cancer. By binding to ENL, these RNA molecules promote the assembly of these condensates, leading to amplified oncogenic gene expression and ultimately, tumorigenesis.

What Problem Does This Paper Address?

Cancer cells often hijack normal cellular processes to promote uncontrolled growth. One such process involves the formation of protein "condensates" – dense, localized assemblies of proteins that can regulate gene expression. Aberrant condensates, particularly those involving the protein ENL, are implicated in driving certain leukemias and Wilms tumors. While the intrinsic properties of ENL mutations are known to promote condensate formation, how the surrounding cellular environment influences these pathogenic condensates has remained unclear. This paper investigates the role of RNA, a known component of many cellular condensates, in modulating the formation and function of these cancer-driving ENL condensates.

Methods

The researchers employed a multi-pronged approach:

  • In vitro binding assays (EMSA): To determine if ENL directly binds RNA and DNA.
  • Computational modeling (AlphaFold3): To predict potential RNA-binding regions within ENL.
  • Cellular RNA-binding assays (CLAP-seq): To identify RNA molecules that bind to ENL within living cells.
  • In vitro droplet assays: To observe and quantify condensate formation by purified ENL protein in the presence or absence of RNA.
  • Immunofluorescence microscopy: To visualize ENL condensates in cells and their colocalization with target genes.
  • Chromatin Immunoprecipitation followed by quantitative PCR (ChIP-qPCR) and sequencing (ChIP-seq): To assess ENL's binding to chromatin at specific genomic loci and genome-wide.
  • RNA sequencing (RNA-seq): To measure changes in gene expression.
  • Chemically induced condensate displacement and re-nucleation: A novel system to study how condensates reform after being disrupted.
  • Mouse models: To assess the role of ENL-RNA interactions in leukemogenesis.

Datasets

  • RNA sequences: ~100 diverse RNA sequences were used for AlphaFold3 modeling.
  • CLAP-seq data: Generated from HEK293 cells expressing wildtype ENL (ENL-WT) and oncogenic ENL-T1 mutant.
  • ChIP-seq data: Generated from HEK293 and MDA-MB-231 cells expressing FLAG-ENL variants.
  • RNA-seq data: Generated from HEK293 and MDA-MB-231 cells expressing ENL variants.
  • Publicly available datasets: Mentioned for GSEA analysis (e.g., LSK_T1 top-bound genes, HUANG AML LSC47).

Key Insights and Ideas

  • RNA as a crucial cofactor: The study reveals that RNA isn't just a passive bystander but an active player in promoting ENL-driven cancer. It acts as a critical cofactor for ENL's oncogenic activity.
  • Specific RNA binding site: ENL's YEATS domain, known for binding acetylated histones, also harbors a conserved basic patch that directly interacts with RNA. This dual binding capability is key.
  • RNA-dependent condensate nucleation: RNA binding is not just about stabilizing condensates; it's essential for their initial formation (nucleation) at specific genomic locations.
  • Targeted recruitment: RNA binding preferentially enhances ENL's presence at "condensate-permissive" genomic sites, suggesting a mechanism for targeting these pathogenic condensates to specific oncogenic loci.
  • RNA's role in transcriptional bursting: The presence of ENL-RNA condensates leads to increased "transcriptional bursting" – periods of intense gene activity – which is critical for driving cancer.

Key Results

  • ENL binds RNA: Both in vitro and in cells, ENL was shown to bind RNA, primarily through a basic patch in its YEATS domain.
  • RNA enhances ENL condensate formation: In vitro droplet assays showed that RNA significantly boosted the formation of ENL condensates, especially for oncogenic ENL mutants.
  • RNA binding is critical for ENL condensate formation in cells: Mutating the RNA-binding site in ENL (T1-3A variant) partially reduced condensate formation in various cell lines.
  • ENL-RNA interactions promote condensate localization to target genes: In HEK293 cells, ENL condensates colocalized with HOXA and CBX3 loci, and this colocalization was reduced in the RNA-binding deficient mutant.
  • RNA binding enhances oncogenic gene activation: Disrupting ENL-RNA interactions led to reduced transcriptional bursting and activation of key oncogenic target genes.
  • RNA binding is essential for leukemogenesis: In mouse models, impairing ENL-RNA interactions significantly suppressed ENL mutant-driven leukemia development.

Limitations and Future Work

  • Defining condensate-permissive loci: The study identifies that only a "small, cell type-specific subset" of target sites is permissive to condensate formation, but the molecular features defining these loci remain to be elucidated.
  • Broader implications of RNA-dependent condensate regulation: The authors suggest that RNA-dependent condensate regulation might be a broader strategy used by cancer cells to achieve persistent pathogenic gene activation, a hypothesis that warrants further investigation.
  • Specific RNA species: While intron-containing RNA transcripts proximal to target genes are suggested as key RNA species, further work could pinpoint the exact RNA molecules involved.

Summary updated

Abstract

ABSTRACT Aberrant chromatin-associated condensates have emerged as drivers of transcriptional dysregulation in cancer. Although extensive studies have elucidated intrinsic protein sequence features governing their formation, how extrinsic factors within the chromatin environment modulate their assembly and pathogenic function remains poorly understood. Gain-of-function mutations in the histone acetylation reader ENL, found in pediatric leukemia and Wilms tumor, drive oncogenesis by inducing condensate formation at highly selective genomic loci. Here, we uncover a critical role for locally produced gene transcripts in reinforcing the nucleation, chromatin engagement, and oncogenic activity of ENL mutant condensates. Mutant ENL binds RNA in part through a conserved basic patch within its YEATS domain, and this interaction enhances condensate formation both in vitro and across diverse cellular contexts. Using a chemically inducible condensate displacement and re-nucleation system, we show that blocking ENL–RNA interactions or transcription impairs condensate reformation at endogenous targets. RNA interactions preferentially enhance mutant ENL occupancy at top-bound, condensate-permissive loci, leading to increased transcriptional bursting and robust gene activation at the single-cell and single-allele level. In mouse models, disrupting ENL–RNA interactions reduces condensate formation and oncogenic transcription in hematopoietic stem and progenitor cells, thereby suppressing ENL mutant-driven leukemogenesis. Together, these findings demonstrate that locally produced RNA transcripts can promote locus-specific nucleation of pathogenic condensates on chromatin, which in turn drive persistent and hyperactive transcription of oncogenic targets and lead to tumorigenesis.
BibTeX
@misc{budinich2025rna,
  author = {Krista A. Budinich and Xinyi Yao and Chujie Gong and Lele Song and Xiaoting Wang and Michelle Lee and Sylvia Tang and Qinglan Li and Sylvia Tang and Son C. Nguyen and Eric F. Joyce and Yuanyuan Li and Haitao Li and Haitao Li and Liling Wan},
  title = {{RNA reinforces condensate nucleation on chromatin to amplify oncogenic transcription}},
  year = {2025},
  doi = {10.1101/2025.07.29.665963},
  howpublished = {bioRxiv},
}
Figure